Joana Goncalves
Known title: Chief Medical OfficerCIK: 0001756991
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Tvardi releases preclinical data on STAT3 inhibitor for UC. Tvardi Therapeutics reported new preclinical results that show its STAT3 inhibitor may be effective in treating ulcerative colitis. The data were published in the International Journal of Molecular Sciences. The announcement appeared in recent market round‑ups of health‑care stocks moving in pre‑market and after‑hours sessions.
Transaction History
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 9/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 9/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,384 | $217K | 9/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 3,150 | $290K | 9/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 1,366 | $127K | 9/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 100 | $9K | 9/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 947 | $91K | 9/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 900 | $99K | 8/17/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 300 | $33K | 8/17/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,480 | $279K | 8/17/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 3,320 | $372K | 8/17/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 8/17/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 8/17/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 7/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 7/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 400 | $34K | 7/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,497 | $214K | 7/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 3,803 | $330K | 7/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 300 | $26K | 7/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 6/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 1,636 | $112K | 6/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 5,064 | $352K | 6/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 300 | $21K | 6/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 947 | $66K | 6/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 6/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 5/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 4,800 | $295K | 5/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,100 | $131K | 5/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 100 | $6K | 5/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 5/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 500 | $34K | 4/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,273 | $151K | 4/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 4/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 4/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 4,227 | $278K | 4/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 3/16/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 3/16/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,921 | $117K | 3/16/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,902 | $120K | 3/16/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 1,177 | $49K | 3/16/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 641 | $26K | 3/16/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 2/17/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 2/17/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 6,064 | $196K | 2/17/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 936 | $31K | 2/17/2026 | View on chart |
| ORKA | ▲ Buy | Grant | 32,500 | $0 | 1/23/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 1/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 1/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 4,381 | $138K | 1/15/2026 | View on chart |
| ORKA | ▼ Sell | Open Market | 2,619 | $84K | 1/15/2026 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $24K | 12/19/2025 | View on chart |
| ORKA | ▲ Buy | Option Exercise | 3,500 | $27K | 12/19/2025 | View on chart |
| ORKA | ▼ Sell | Open Market | 641 | $18K | 12/19/2025 | View on chart |
| ORKA | ▼ Sell | Open Market | 1,787 | $53K | 12/19/2025 | View on chart |
| ORKA | ▼ Sell | Open Market | 1,492 | $46K | 12/19/2025 | View on chart |
| ORKA | ▼ Sell | Open Market | 3,080 | $97K | 12/19/2025 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,753 | $2K | 4/5/2024 | View on chart |
| TVRD | ▼ Sell | Open Market | 3,293 | $3K | 2/29/2024 | View on chart |
| TVRD | ▲ Buy | Grant | 13,500 | $0 | 2/1/2024 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,723 | $10K | 6/23/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,481 | $12K | 4/4/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 6,221 | $60K | 3/3/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,265 | $23K | 2/16/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 7,770 | $4K | 2/8/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,265 | $24K | 1/17/2023 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,265 | $23K | 12/29/2022 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,992 | $34K | 12/21/2022 | View on chart |
| TVRD | ▼ Sell | Open Market | 1,642 | $20K | 4/1/2022 | View on chart |
| TVRD | ▲ Buy | Grant | 20,000 | $0 | 2/25/2022 | View on chart |
| TVRD | ▼ Sell | Open Market | 1,972 | $20K | 2/25/2022 | View on chart |
| TVRD | ▲ Buy | Grant | 12,607 | $0 | 12/17/2021 | View on chart |
| TVRD | ▼ Sell | Open Market | 1,000 | $17K | 11/1/2021 | View on chart |
| TVRD | ▼ Sell | Open Market | 1,000 | $15K | 10/27/2021 | View on chart |
| TVRD | ▼ Sell | Open Market | 2,110 | $30K | 8/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
HC Wainwright Reiterates $120 Target on Oruka
HC Wainwright maintained its buy rating on Oruka Therapeutics, keeping its price target at $120. The firm continues to see the company favorably despite recent trading levels well below that target. The analyst consensus average for the stock stands at $153.75, with estimates ranging from $102 to $200.
HC Wainwright Reiterates $120 Target on Oruka. HC Wainwright maintained its buy rating on Oruka Therapeutics, keeping its price target at $120. The firm continues to see the company favorably despite recent trading levels well below that target. The analyst consensus average for the stock stands at $153.75, with estimates ranging from $102 to $200.